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ABSTRACT

Attention Deficit Hyperactivity Disorder in Adolescents and the use of Ritalin
Submitted by: Joanne Nelson
1998
Advisor: Dr. S. Jay Kuder
Master of Arts in Special Education

The purpose of this study was to see if a combined stimulant intervention/behavior
improvement system facilitated greater gains on achievement tests and on a behavior
improvement level system than a behavior improvement system alone with ADHD
adolescents. The sample used consisted of 10 subjects classified with ADHD. Subjects
were matched for IQ, age, educational classification and placement, socioeconomic status,
and family type. Five subjects received stimulants and five received no medication, but all
subjects were involved with the behavior improvement system at school. Pretest results
were gathered using the KTEA (Kaufman Test of Educational Achievement, brief form)
and the student's standing on the behavior improvement system. Post test scores from the
same two instruments were then gather for comparison. Although statistical tests were not
significant, these results hold practical significance as demonstrated by the larger grade
level gains made by the stimulant group in all areas tested (e.g. reading +1.80 grade levels
for medicated vs. +0.52 for non-medicated). It is believed that further research needs to be
conducted with larger samples who have less variability within each sample to get more
accurate results.

ABSTRACT

Attention Deficit Hyperactivity Disorder in Adolescents and the use of Ritalin
Submitted by: Joanne Nelson
1998
Advisor: Dr. S. Jay Kuder
Master of Arts in Special Education

The purpose of this study was to see if the use of stimulants improved ADHD
adolescent's cognitive and behavior achievements.

Although statistical tests were not

significant, these results hold practical significance as demonstrated by the larger grade
level gains made by the stimulant group in the classroom.
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Chapter One
Approximately 3-5% of all American children, up to 3.5 million children, have an
Attention Deficit Disorder (ADD). ADD and ADHD (with hyperactivity) are a primary
sources of school failure and under-achievement.

ADD and ADHD are frequently

accompanied by poor self-esteem and behavioral challenges.

These disorders are

neurobiologically based ( CH.A.D.D., 1995).
Interventions for Attention Deficit Hyperactivity Disorder can involve medication,
behavioral therapy, parental training, diet, and/or a change in educational placement, just to
name a few. The topic of this thesis involves stimulant drugs, like Ritalin, its uses, effects,
history, and changing research on this topic as it applies to ADHD in adolescents.
In the past, it has been common for doctors to discontinue stimulant drugs when a
child reaches puberty. Some of the side effects of drugs like Ritalin usually involve loss of
appetite, which may effect growth. The purpose of discontinuing drug use was to allow
the adolescent to go through this natural growth spurt and reach their full potential size.
Another fear of many parents was the continuing use of a controlled dangerous substance,
or C.D.S., like Ritalin may lead to drug addiction problems later. Some parents state that
by the time an ADHD child reaches adolescence, the child should become more responsible
for their own behavior and exhibit better control.
On the other hand, stimulant medications have helped children achieve better in
school by allowing the student to focus their attention and control their impulses. These
abilities can help children academically in the classroom, socially and/or behaviorally on the
playground, as well as to improve their self esteem through personal achievements at
school and at home.
As a teacher of emotionally disturbed junior high school students, and as a parent
of an ADHD 13 year old, I have a personal and professional interest in this debate over
1

whether to use stimulant drugs during adolescence. I have seen the benefits academically in
the classroom as demonstrated by an ADHD child's ability to focus and learn from a lesson
presented. I have seen a child smile simply because he has completed an assignment on
time and earned a reward for it. And I have seen children become less involved in
aggressive responses, and choosing solutions with more thought during social situations
with their peers.
The pros and cons of whether or not to place these children on drug therapy can
haunt parents and teachers alike. Academic and social growth are goals they both are
striving for. Therefore, parents and teachers must ask themselves what are the effects of
stimulants on academic performance? Do ADHD children not on stimulants make the same
academic achievements as ADHD children on stimulants? On the other hand, will ADHD
students on stimulants achieve more academic growth than ADHD students not on
stimulants? Also, questions relating to the effects of the social achievement of ADHD
children on stimulants as compared to ADHD children not on stimulants should be
addressed.
Statement of Problem
This raises an important question: Do ADHD adolescent junior high school
students, who are taking Ritalin, demonstrate larger increases in achievement in school, as
shown by the Fall and Spring achievement tests and behavioral measures, than ADHD
adolescent junior high school students who are not taking Ritalin?
Hypotheses
I hypothesize that ADHD adolescent students who are taking Ritalin will
demonstrate larger increases in mean standard score on the Kaufman Test of Educational
Achievement (KTEA) when comparing Fall and Spring standard scores than ADHD
adolescent students who are not using Ritalin intervention. I also hypothesize that ADHD
adolescent students who are taking Ritalin will achieve a higher status on a behavior
improvement system than ADHD adolescent students who are not using Ritalin
intervention.
Definitions
Attention Deficit Disorders were previously known as Minimal Brain Dysfunction
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in Children, Hyperkinetic Child Syndrome, Minimal Brain Damage, Minimal Cerebral
Dysfunction and Minor Cerebral Dysfunction.

ADHD is now called Attention Deficit

Hyperactivity Disorder and is defined according to the Diagnostic and Statistical Manual of
Mental Disorders (DSM-IV, American Psychiatric Association, 1994) as:
A. Either(1) or (2)
(1). Inattention. At least six or more of the following symptoms of inattention
which has persisted for at least six months to a degree that is maladaptive and
inconsistent with the developmental level of the child:
(a) often fails to give close attention to detail or makes careless mistakes
in schoolwork, work, or other activities.
(b) often has difficulty sustaining attention in tasks or play activities
(c) often does not seem to listen when spoken to directly
(d) often does not follow through on instructions and fails to finish
schoolwork, chores, or duties in the workplace (not due to
oppositional behavior or failure to understand instructions)
(e) often has difficulty organizing tasks and activities
(f) often avoids, dislikes, or is reluctant to engage in tasks that require
sustained mental effort (such as schoolwork or homework)
(g) often loses things necessary for tasks or activities (e.g., toys, school
assignments, pencils, books, or tools)
(h) is often easily distracted by extraneous stimuli
(i) is often forgetful in daily activities
(2). Impulsivity-Hyperactivity. At least six (or more) of the following
symptoms which has persisted for at least 6 months to a degree that is maladaptive
and inconsistent with their developmental level:
Hyperactivity
(a) often fidgets with hands or feet or squirms in seat
(b) often leaves seat in classroom or in other situations in which remaining
seated is expected
(c) often runs about or climbs excessively in situations in which it is
inappropriate (in adolescents or adults, may be limited to subjective
feelings of restlessness)
(d) often has difficulty playing or engaging in leisure activities quietly
(e) is often on the "go" or often acts as if "driven by a motor"
(f) often talks excessively
Impulsivity
(g) often blurts out answers before questions have been completed
(h) often has difficulty awaiting turn
(i) often interrupts or intrudes on others (e.g., butts into conversations or
games)
B. Some hyperactive-impulsive or inattentive symptoms that caused impairment were
present before age seven.
C. Some impairment from the symptoms is present in two or more settings (e.g., at school
[or work] and at home)
3

D. There must be clear evidence of clinically significant impairment in social, academics, or
occupational functioning
E. The symptoms do not occur exclusively during the course of a pervasive Developmental
Disorder and are not better accounted for by another mental disorder (e.g., Mood Disorder,
Anxiety Disorder, Dissociative Disorder, or a Personality Disorder)
Ritalin or methylphenidate hydrochloride USP is described in the Physician's Desk
Reference (P.D.R.) as a mild central nervous system stimulant (44th Edition, 1990). The
P.D.R. continues to state that the mode and action in man is not completely understood, but
Ritalin presumably activates the brain stem arousal system and cortex to produce its
stimulant effect.
A behavior improvement system is a system of positive reinforcements, negative
reinforcements, and punishments designed to extinguish unwanted behaviors by replacing
them with desired behaviors. Behavior improvement systems typically consist primarily of
positive reinforcement of desired behavior that may include: non-verbal reinforcement
(e.g., a smile), verbal praise, a positive phone call home, a touch (e.g., pat on shoulder), a
tangible reward (e.g., token, food), and privileges (e.g., extra P.E.). Secondary to a
behavior improvement system are a list of negative reinforcers and punishments which may
include: delay of a desired activity until completion of an assignment ( e.g.recess after math
is completed), a phone or letter home informing parents of negative behavior, removal from
situation (e.g., time out, in-school suspension), or punishment (e.g., detention,
suspension, fine from token economy).
Behavioral improvement systems usually consist of a type of level system where
students who have met certain behavioral requirements move up to the next level. These
levels usually involve progressively more privileges and more trust on the part of the child.
The child's goal is to obtain the highest level by increasing desired behaviors (e.g., being
on-task) and decreasing unwanted behaviors (e.g., acts of aggression).

Purpose
The purpose of this research study is to determine if students with ADHD who are
taking stimulant medication achieve at higher levels and have more positive social behavior
than similar students not on medication. If stimulant usage proves effective in adolescence,
then these older children can benefit from its use. This is important because in the past,
4

stimulants where used only during childhood years (e.g., 6-12). More recently, doctors
are prescribing stimulants to adolescents and adults with ADHD so that continued benefits
from this medication can help them through high school and into adulthood. The families
involved with these adolescents, as well as their teachers, will find the results of this study
important because of the possibility for both academic and behavioral growth.

The

students themselves can experience success and therefore improve their self image. I hope
to find a positive relationship between the use of stimulant medication and success in
school for these older ADHD children.
There are certain implications of the possible findings in this research study. First,
if stimulant medications are found to increase academic and social achievements, than
should they be used with all ADHD adolescent students? Second, what if the increase in
academic and social achievements is not significant or what if there is no difference at all?
Also, what if significant achievements in school are not related to whether the student is on
medication, but are found to be related to the amount of the dose (e.g., mg./kg)? What if
the side effects out-weigh the educational benefits of the medication? What if the parent,
teacher, and/or doctor disagree about whether the educational benefits are not significant
enough to warrant continuing drug therapy?
In the chapters that follow there will be more detailed information about ADHD and
this research study. In chapter II, an extensive review of the literature will be conducted
involving literature supporting both sides of the stimulant issue. In chapter III, the design
of the actual research study will be laid out in detail. In chapter IV, the results of the
research will be presented using charts, graphs, tables and script. Finally, in chapter V, a
discussion will be presented detailing what was found, possible reasons for such findings,
interpretation of the data, and predictions for future research pertaining to the topic.

5

Chapter Two

Background on ADHD
Attention Deficit Hyperactivity Disorder has been one of the most researched topics
in the education of children with special needs today (Dulcan, 1997). ADHD is also the
most common psychiatric disorder of childhood (Swanson, Cantwell, Lerner, McBurett,
& Hanna, 1991). The history of this disorder (called many other names in its development)
dates back to the early 1900's when it was considered some type of brain damage, a
traumatic brain injury, or "morbid defects in moral control" (Still, 1902: as cited in
Greenhill & Osman, 1991). In the 1950's the causes were thought to center around a brain
dysfunction, not damage. Today, ADHD is a low visibility but highly prevalent disorder
that can effect every part of a child's life, from school, to home, to playground and later to
work or to job sites, ADHD, as it is defined today in the Diagnostic and Statistical Manual
of Mental Disorders, fourth edition (DSM-IV), is manifested by inattentiveness,
hyperactivity, and/or impulsiveness, displayed through a variety of behaviors (eg.
distractible, unable to stay seated, calling out in class, difficulty waiting turns, etc.) for a
period of time (longer than six months) and in different environments (in the classroom, at
home, on the playground, etc.) which is not caused by another mental disorder. It is also
the most common neurobehavioral disorder of childhood (DSM-IV, American Psychiatric
Association, 1994). Shaywitz & Shaywitz, in 1988, estimated that ADHD now affects as
many as 10-20% of the school-aged population (cited in Greenhill & Osman, Eds. 1991).
Researchers have looked for neurologically based evidence of brain differences in
children and adolescents with ADHD using MRI and PET imaging technology. Some have
found differences in both the caudate and corpus callosum sections of the brain in shape
and size ( Castellanos et. al., Hynd, Hem, et al., Giedd et. al., Sermud-Clikeman, Filipek
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et al., as cited in Seidman, Biederman, Farone, Weber and Oullette, 1997). Other findings
by Zametkin were related to actual brain structure or function that included a difference in
cerebral metabolism (as cited in Seidman et al., 1997). Furthermore, reductions of the
frontal area of the brain were found in ADHD children by Hynd, Semrud-Clikeman, Lorys,
Novey & Eliopulos (as cited in Seidman et al., 1997).
Assessment and treatment practice parameters for children, adolescents, and adults
have been reviewed and updated over the years (Dulcan, 1997). Currently, assessment of
ADHD in children and adolescents includes a review of school-related data such as reports
of behavior, learning, and attendance.

Rating scales filled out by the teachers and the

parents also provide valuable information.

The student should be observed using

structured observation techniques (e.g. standardized checklist) in the classroom and in less
structured settings like the playground and lunchroom.

A medical evaluation, which

includes a complete medical history (including pregnancy history), vision and hearing
exams, blood tests for lead, and a thyroid dysfunction check, should be conducted.
After looking at the results of the various diagnostic tests used to determine if a
child has an attention deficit disorder, the student's individual problems should be
addressed.

Some students may have the bulk of their problems in the category of

hyperactivity, while others may be impulsive or inattentive. A majority exhibit problems in
two or all three of these areas.
The neuropsychology of ADHD is the study of brain behavior relationships (e.g.
intellectual functioning, attention/concentration functioning, memory functioning, language
functioning, spatial functioning and executive functioning, [J. Zielinski, personal
communication, October 25, 19971) and was the topic of a research study out of
Massachusetts General Hospital (Seidamn, Biederman, Farone, Weber and Oullette, 1997).
The performances on tests of neuropsychological functions of both ADHD children and
adolescents were compared. The neuropsychological performances of the ADHD children
were significantly impaired when compared to the control group. The brain functioning
findings of Seidman, as well as the brain structural differences, brain size and metabolism
findings of the researchers mentioned previously, are conclusive that ADHD has roots in
neurological and brain composition abnormalities ( Castellanos et. al., Hynd, Hem, et al.,
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Giedd et. al., Sermud-Clikeman, Filipek et al., Zametkin et al., as cited in Seidman,
Biederman, Farone, Weber and Oullette, 1997).
Treatment of ADHD and the Use of Stimulants
Treatment of ADHD may include psychosocial interventions, environmental
modifications, principles of behavior modification, medication (usually a central nervous
system stimulants like methylphenidate), parent training, family counseling, education
through support groups, and educational adjustments. For 60 years the primary treatment
for ADHD (the name has changed frequently through the years) has been the use of
pharmacological intervention with one of the central nervous system stimulant drugs like damphetamine (Dexedrine) and pemoline (Cylert) (Swanson, Cantwell, Lerner, McBumett
& Hanna, 1991). Amphetamine sulfate (Benzedrine) and its use in behavior disordered
children was first reported by Bradley in 1937 when he reported this stimulant to have a
positive effect on the academic achievement (cited in Gadow, 1983). Methylphenidate was
first introduced in 1955 as a hopefully nonhabituating alternative to Dexedrine and other
amphetamines for the treatment of hyperactivity in children (Wiener, 1991). The use of
stimulant medication, like Ritalin, with children has received the most controversy.
Stimulant use as part of the treatment of ADHD in children can have a positive
effect on their cognitive, learning and academic performances. Results from the use of
methylphenidate in ADHD children can be seen as increased output, accuracy, efficiency,
improved learning acquisitions, increased effect, and increased self-correcting behaviors
(Douglas, Barr, O'Neil, & Britton, 1986).
Usually for more severe cases, stimulant medication is used in combination with
other modifications, education, support groups, additional medications, and/or counseling.
A study conducted in 1993 (Pelham, Carlson, Sams, Vallano, Dixon, & Hoza) measured
the effects of stimulant intervention alone, behavior modification alone, and stimulant and
behavior modification used together. Results showed that using the behavior modification
alone tended to increase on-task behavior significantly more than stimulants. However,
stimulants alone produced significant improvement in all measures except seat work
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accuracy (e.g. disruptive behavior, physical aggression, verbal abuse, destruction of
property, cheating, verbal intrusion, social validity {e.g. like a normal child or pleasant},
and following rules).

Combined intervention (stimulants and behavior improvement)

produced significant improvements for all measures. Children were also more likely to be
rated as very pleasant on the social validity scale when involved in either stimulants alone or
in combination with behavior improvements as opposed to behavior improvement
intervention alone. All treatments in this study were shown not to generalize into nonintervention periods (Pelham et al., 1993). Several other authors, who have conducted
similar studies, found that medications may improve some behaviors while behavior
modification improved other symptoms in the same subject (Pelham & Murphy, 1986, as
cited in Pelham, Carlson, Sams, Vallano, Dixon, & Hoza, 1993). This further supports
the benefits of a combined treatment of stimulants and behavior modification.
The use of methylphenidate can improve the symptoms of ADHD children in the
classroom. But improvements in other situations (e.g. home) and times (e.g. morning and
afternoon) may not be as significant (Schachar, Tannock, Cunningham, & Corkum, 1997).
Often side effects become a problem for some children. Some of these side effects may
include: insomnia, dizziness, anorexia, headache, daytime drowsiness, irritability, sadness,
crying, tics or over focusing. In a study conducted in Canada (Schachar et al., 1997),
subjects were given either a placebo or methylphenidate twice a day (morning and lunch
time) for four months. Baseline information on behavior at home and school, at different
times of the day, different lengths into the study, as well as height and weight measures
were obtained. The results showed that more children were withdrawn from the stimulant
group in this study due to side effects of the medication than were withdrawn from the
placebo group. Weight increase in the methylphenidate group was -.4 kg. as compared to
+1.2 kg. with the placebo group, yet both groups demonstrated approximately +2 cm. in
height in the four month study. Benefits of the stimulant group's behavior were only seen
in the school setting. This may be due to loss of drug effectiveness by the time the child got
home or from rebound effects which could have been alleviated by a third late afternoon
dose. Some side effects noted may have been due to actual symptoms of ADHD and not
due to medication. Finally, teachers noticed more behavior improvements and less side
9

effects, and parents noticed less behavior improvements and more side effects. These
findings could be due to the time the doses were administered, and the different behavioral
expectations of the teacher and the parent. Usually treatment with stimulants lasts over
several years and although short term benefits and risks have been studied, extended use of
stimulants is not as well understood. We do not know whether the side effects evident in
short term studies diminish or increase over time, or if other side effects appear at a later
date.
Teachers may demonstrate different attitudes towards ADHD children who are
taking methylphenidate than ADHD children who are not taking methylphenidate ( Whalen,
Henker, & Dotemoto, 1980). It was observed that ADHD children on placebos received
more intense and controlling negative verbal interactions than those students on stimulants
or the controls. Also, the placebo group were more often referred to by name (referring to
the child instead of the behavior) than the other two groups. An implication of the results
of this study may be the effect of medication on others in the classroom who are not
ADHD. The teacher tends to spend more time correcting non-medicated ADHD children
which can impinge on the time available for other students in the classroom.
Many symptoms pertaining to success in the classroom of ADHD children have
been controlled by stimulants. Yet another problematic area still exists for many ADHD
students: the area of social skills. The peers of ADHD students may be cautious about
starting friendships with others who tend to be difficult and disruptive. The social impact
of stimulant treatment for hyperactive children has also been reviewed in a report by
Whalen & Henker (1991). The ADHD child in this study frequently initiated social contact
with peers but in a way perceived as immature, intrusive, or aggressive. Some of these
behaviors may in fact be the result of their difficulty in dealing with frustration. ADHD
children seem less able to adjust their behaviors in agreement with social cues. The use of
stimulants, in addition to enhancing concentration and cognition, also improves
interpersonal cooperation.
Relationships between ADHD children and their mothers showed a decrease in
maternal criticism and an increase in maternal warmth and mother-child contact following
stimulant treatment (Schachar, Taylor, Wieselberg, Thorley, & Rutter, 1987; as cited in
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Whalen & Henker, 1991). Situations in the home may also benefit by the child being more
focused and compliant with parents and less controlling and domineering with peers
(Barkley, Karsson, Pollard, & Murphy, 1985; Cunningham, Siegel, & Offord, 1985; as
cited in Whalen & Henker, 1991).
Situations involving organized sports where ADHD children were often selected
last due to skill deficits and misbehavior, also seem to benefit from stimulant intervention.
Stimulants did not improve baseball skills, but did have a positive effect on attending and
following the action. Teammates tended to overlook skill deficits like poor batting, but
were less likely to forgive a teammate who was facing the wrong way or throwing his
glove in the air (Whalen & Henker, 1991).
Non-disabled children view the behaviors associated with ADHD as undesirable
and negative. This raises the question of peer status with ADHD children.

Stimulant

medication and the perceptions of the peers of children with ADHD is a concern.
Methylphenidate, in a study conducted in 1989, did improve the ADHD child's standing in
the peer group. The medicated boys were more likely to be named best friends or chosen
as "fun to be with" or cooperative by their peers than those boys receiving a placebo
(Whalen, C. K., Henker, B., Burrmester, D., Hinshaw, S. P., Huber, A., & Laski, K.
1989). Apparently, this improvement was dose related with the greatest improvements at
the .6mg/kg level as compared to the .3mg/kg level and placebo. Yet these improvements
were not sufficient enough to upgrade the ADHD child's status to that of normal peers.
The problem here is that ADHD children on stimulants are not continuously medicated.
This leads to a decline in appropriate behaviors around lunchtime or before and after
school. The child may display desirable social-interchanges during the morning only to
have his reputation spoiled by a single unfavorable misbehavior before lunch when his
medication has worn off and before his lunchtime dose has taken effect (Whalen & Henker
1991).
The possibility of side effects from the use, or prolonged use, of stimulant
medications has swayed many parents to withdraw their child from stimulant treatment.
Certain characteristics may lead to a successful withdrawal from medication while other
may burden the process. For example, if the child believes that the medication is no longer
11

useful or necessary then medication termination is less traumatic. But if the child believed
that "good" work and behavior are due solely to medication than the withdrawal from
medication can be detrimental. In a case study by Rosen, Leary and Conway (1985), the
withdrawal of stimulant medication from a 9 year old subject was examined. The subject,
Tom, was given 5mg of methylphenidate twice a day. On the sixth day of the study,
Tom's dose was reduced to 2.5mg/b.i.d.

With the reduction of medication came an

increase in behavioral techniques which included immediate material rewards for following
classroom rules and completing assigned work, as well as daily positive notes home when
Tom met his behavioral and academic goals. Tom's productivity was 93%, completing all
assignments except for one day.

His average time-on-task was 57% per structured

observations. During the third week of school, Tom's prescription had ran out and for 4
days he was without medication.

Tom's productivity dropped to 57% and on-task

percentage dropped to 15%. When asked about his work and behavior, Tom attributed all
his problems to not having his pills. Tom was then placed on a 2.5mg placebo table. His
productivity rose to a mean of 87% and his on task rate increased to a mean of 64%. Tom
attributed his success to his pills. The placebo was then slowly withdrawn while the
teacher began prompting and reinforcing more adaptive and internal attributions to the
causes of his behavior (e.g. "I finished and I did it on my own. I don't need the pills." ).
After complete withdrawal from medication, Tom completed 97% of his assignments and
was on task an average of 71% of the time for 5 days of observations.
After completing third grade, Tom started fourth grade with positive results and
drug free. However, Tom's behavior went downhill and Tom was placed back on 5mg of
Ritalin. When Tom was complemented on his behavior, he stated that it wasn't him it was
the Ritalin. Tom also started fifth grade without Ritalin but because the teacher wouldn't
institute a behavior modification program, Tom's mother put him back on medication
(Rosen, Leary and Conway, 1985). The earlier results of Tom's success did not generalize
to other situations.
The problem with the Rosen, Leary and Conway (1985) study was that it only dealt
with a single subject but it brings up an important topic.

Many believed that just the

thought of using a drug to improve school performance would increase the child's
12

perception of their performance citing the drug as the reason for their success.

In another

study conducted, 26 subjects were used as opposed to just one. In contrast, ADHD boys
who were given the same task with medication and then with a placebo attributed their
success significantly more often to their effort than to the medication (Milich, Licht,
Murphy, & Pelham, 1989). This study, too, had a methodological flaw. The subject either
received their medication or a placebo, yet a third condition could have been added by
giving no pill at all. Because the subjects believed they were on medications during both
sessions, the results did not address whether there are self-evaluation differences
associated with knowing if one is on methylphenidate or not.
The controversy involved in the use of methylphenidate often centers around the
possible side effects. One of the reported side effects of stimulant drugs is the threat of
growth retardation. A study by Klein and Mannuzza (1988) looked at young adults who
were treated with methylphenidate in childhood to determine if their ultimate height was
effected. The ADHD children in the study were treated on the average with 45mg. per day
for an average of two years when they were between the ages of 6-12. When the subjects'
height was evaluated during drug treatment, their growth rate was found to be adversely
affected. However, this longitudinal study found that when compared to a control group of
same age peers, there was no significant height difference when the children had reached an
average age of between 16-23 years of age. In a study by Hechtman, Weiss, and Perlman
(1984), similar findings were concluded between ADHD adults who were stimulant-treated
as children, ADHD adults who were untreated, and control group adults. The subjects
demonstrated equivalent height and weight achievements. The findings in these studies
support the theory of growth rebound after the removal of methylphenidate treatment.
Also, genetic influence and parental stature must be considered in the ultimate height
reached by any child. Other factors that may effect growth is the comorbidity of other
disorders with ADHD. For example, conduct, mood, and anxiety disorders might also
affect growth (Biederman, Newcorn, & Sprich, 1991, as sited in Spencer, Biederman,
Harding, O'Donnell, Parone, & Wilens, 1996).
Growth deficits in both height and weight and their possible link to stimulant use
were studied at Massachusetts General Hospital and Harvard Medical School (Spencer,
13

Biederman, Harding, O'Donnell, Parone, & Wilens, 1996). They found that there was a
modest height difference in the ADHD patients as compared with controls. These height
deficits were not evident after early adolescence. Furthermore, they found no evidence of
delayed puberty development or weight deficits. These results are consistent with the
hypothesis that ADHD may be related to a delayed tempo of growth in height, and not to
impeded growth due to complications of stimulant treatment (Spencer et al., 1996).
Another side effect of psycho stimulant medication is rebound. Rebound effects
are defined as the decline in behavior that takes place in the late afternoon and evening
following daytime administrations of stimulants (Johnston, Pelham, Hoza, & Sturges,
1988). In a placebo, .3mg/kg dose and a .6mg/kg dose blind study, the results provided
limited evidence for behavioral rebound effects in boys taking a morning and noontime
dose of stimulants. Also, on the two different measures used, results varied enough to
warrant them inconclusive. Rebound effects of the use of methylphenidate not investigated
in this study, which may need further study, may be delayed sleep onset, lengthened sleep
and changes in REM variables among ADD children.
The use of stimulant medications have been discussed thus far as it relates mainly to
the use of methylphenidate or Ritalin. Many other stimulant medications are also available
for the treatment of ADHD. The different effects of these stimulants should be compared.
In a study by Pelham and others in 1990, sustained-released methylphenidate, sustainedreleased dextroamphetamine, pemoline, and standard methylphenidate were compared. The
dependent variables studied were social behaviors, classroom performance,

and

performance on continuous performance tasks. What was found in this study was that
sustained-released dextroamphetamine and pemoline produced the most consistent results
(Pelham, Greenslade, Vodde-Hamilton, Murphy, Greenstein, Gnagy, Guthrie, Hoover, &
Dahl, 1990). Also, the effects of the sustained-released stimulants lasted for 9 hours.
Since the medications were given on random days, there was a concern about some of the
long-acting medications, specifically pemoline, not reaching its fullest potential.

The

effects of the pemoline was documented on the second and third day and it was found that
the effects were equivalent to the other medications. This contradicts the findings earlier that
it takes 6-8 weeks to see an effect with pemoline. One of the side effects of the long-acting
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stimulants in this study was difficulty falling asleep which subsided by the third day. The
concluding recommendation, for 14 of the 15 children receiving a recommendation for
medication, was treatment with one of the long-acting stimulants as opposed to standard
methylphenidate. Another point to consider is the possibility of a build of the long-acting
stimulants over time since the half-life of these medications are longer than standard
stimulants.
In another study of comparison, the effects of regular methylphenidate and
sustained release methylphenidate were studied to compare their effects on cognitive and
social behavior in ADHD children (Pelham, Sturges, Hoza, Schmidt, Bijlsma, Milich &
Moorer, 1987). The study was divided up into two separate studies. The first one tracked
the effects of the medications on behaviors. The second study tracked the effects across
time. Side effects in these studies did not include difficulty in falling asleep as did in the
above mentioned study (Pelham, Greenslade, Vodde-Hamilton, Murphy, Greenstein,
Gnagy, Guthrie, Hoover, & Dahl, 1990), however appetite suppression was a problem in
an equal number of subjects on standard and sustained-released methylphenidate. The
results demonstrated in the first study was that both forms of methylphenidate had a
positive effect on social and learning dependent variables studied (e.g. rule-following
behavior, positive peer behaviors, classroom productivity and accuracy).

However,

standard methylphenidate had slightly more favorable results in the first study.
In the second study, which looked at how long the effects lasted comparing the
standard

and

long-acting

methylphenidate,

they

found

that

sustained-released

methylphenidate had less variance through the lunch time hour as opposed to the standard
methylphenidate. Long-lasting methylphenidate started to slowly decrease its effects after
four hours.

Effects of the standard methylphenidate were seen faster than sustained-

released stimulants.
In addition to different kinds of stimulant intervention, there are also dose-related
considerations to examine. Classroom academic and social performances of the child can
be effected by dose size in relation to milligrams to kilograms (mg/kg) (Pelham, Bender,
Caddell, Booth, Moorer, 1985). This study used a double-blind, cross-over design with
order randomized. These children, aged 5-11, received a placebo for two weeks, and three
15

different doses of methylphenidate (0.15mg/kg, 0.3mg/kg, and 0.6mg/kg) for one week
each. The dependent variables measured included the output and accuracy of performance
in grade-appropriate reading comprehension workbooks and arithmetic problems, spelling
word acquisition, and observation of disruptive and on-task behavior. The results of this
study indicated that positive effects on academics were achieved at the 0.3mg/kg dose of
methylphenidate yet behavioral improvements maximized at the 0.6mg/kg dose. Also noted
was that arithmetic measures increased slightly more than reading measures.

They

attributed this to the fact that arithmetic improvements tend to come about with drill and
repetition, which is a component of the design of this study.

Increases in spelling

performance was not as significant as both the reading and arithmetic performances but an
intervening variable mentioned by the authors might have been that spelling often tended to
follow a free play period and students entered into the spelling lesson excited. Overall, this
study supports the use of methylphenidate to improve academic and behavior performances
in ADHD children (Pelham, et al. 1985).
In a more recent study, academic performance and overt behavior in hyperactive
children were compared as it relates to different doses of methylphenidate (Tannock,
Schachar, Carr, & Logan, 1989). This study was also a double-blind, placebo-control,
within-subject (crossover) design. Participants were between the ages of 6 and 11 and
were diagnosed with ADHD according to the DSM-III. The effects in this study were
measuring 0.3mg/kg and 1.0mg/kg doses of methylphenidate on academic and behavior
performances. An interesting finding in this study was that with a 0.3mg/kg dose in the
morning there was no longer any academic or behavioral improvements noted in the
afternoon. However, with the 1.0mg/kg dose in the morning, there were still behavioral
improvements noted in the afternoon although the academic improvements had diminished.
As with the other dose-related studies, academics improved at the 0.3mg/kg dose the same
as with the higher dose when compared to placebo, indicating there is no need to increase
the dose to get the desired academic effects in the classroom. Behavior did improve at the
0.3mg/kg dose, however, better improvement occurred at the higher dose when compared
to placebo.
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ADHD in Adolescence
ADHD diagnosed children experience trouble learning due to the symptoms of their
disorder (difficulty with sustained attention, listening skills, distractibility, organizational
skills, etc.) or due to the comorbidity of other learning/behavioral disorders. It was
assumed in earlier years that ADHD did not continue into adolescence or adulthood.
However, these ADHD children usually approached adolescence with continued problems.
Some of the symptoms special to adolescents with ADHD tend to be more restlessness
instead of gross motor hyperactivity.

Fidgeting, out of seat behavior, poor impulse

control, and inattention are still present in adolescence.

The older student may also

experience poor organizational skills, difficulty setting and keeping priorities, and weak
problem-solving strategies (Dulcan, 1997). All these factors contribute to poor school
performance.

The ADHD adolescent may have low self-esteem, increased thoughts of

suicide, experiment with self-medication attempts (especially if unmedicated by a physician)
and substance abuse, and develop poor peer relations.

They also tend to make poor

judgments with the addition of more independence that comes with adolescence, resulting
in decisions that can have dangerous results (e.g. automobile accidents, traffic tickets,etc.)
(Dulcan, 1997).
Students who were classified ADHD have been found to have significantly poorer
educational outcomes as adolescents when compared to same age peers (Lambert, 1988).
In a longitudinal study, conducted by Lambert from the University of California, Berkeley,
ADHD adolescents (ages 17-18) were found to more frequently attend special schools, not
finish high school, not go on to college, leave school or run away, live away from school
in foster care or residential settings, and were more often adjudicated delinquents.
However, an interesting finding in this study was that children diagnosed and treated for
hyperactivity medically were more likely to smoke cigarettes, yet less likely to abuse illegal
substances than their control group (Lambert, 1988).
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Medication Use in Adolescence

As the ADHD child grows into adolescence and then into adulthood, the long term
effects of stimulant usage must be considered. Conversely, the ADHD adult who did not
receive stimulant treatment as a child should be looked at to discover the effects on the
ADHD adult who did and did not receive stimulant medications as a child. In a study by
Hechtman, Weiss, and Perlman (1984), ADHD adults who were treated with stimulants as
children, ADHD adults untreated as children and a non-ADHD untreated control group
were reviewed. What they found was that the control group did better in all areas tested
(e.g. schooling, school-guidance questionnaire, employer questionnaire, work records,
debts, personality disorders, some psychological tests, etc.) than both the treated and
untreated hyperactive groups.

Interestingly, there were a few areas that the stimulant

treated group did better than the untreated group.

These areas included: fewer car

accidents, seeing their childhood more positively, stealing less in elementary school, and
generally having better social skills and self-esteem. Stimulant-treated hyperactives were
more involved in alcohol and stimulant use when compared with their controls, but
untreated hyperactives were involved with more heroin use (Hechtman et al, 1984).
Most parents, teachers, physicians, and others concerned with the ADHD
child, are focused mainly with improving the academic achievement of the child. The
frustration level of the ADHD child becomes apparent typically when the child is challenged
academically. Therefore increasing the child's academic levels without increasing their
frustration is an accomplishment all are striving for.

The cognitive effects of

methylphenidate on the ADHD child, which may include information-processing, were the
focus of a study in 1994 (Klorman, Burmaghim, Fitzpatrick, Borgstedt & Strauss).
Subjects received methylphenidate or placebo for 21 consecutive days in random order and
under blind conditions. The average dose received by each subject .76mg/kg. The results
were a generality of improvements in the subjects who received stimulants. Also noted in
this study was that maturation had similar effects on performance as did methylphenidate.
This is an indication that as the ADHD child grows into adolescence and adulthood, there
may be less of a need for stimulants or a need for a smaller dose (mg/kg).
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One of the hardest school situations for an ADHD child to succeed in is the lecture
format classroom. This is often the case in ADHD adolescents where lectured lessons are
used more frequently. Not only does the child have to focus on the lecture, take notes,
write and listen at the same time, but he also has to ignore others who may be off task and
keep their own behavior in check, especially when they feel frustrated at the speed of the
lecture. Junior high school students who are not ADHD can feel overwhelmed by the
changes and added responsibilities of junior high school life. The use of stimulants in
adolescents in junior high has been studied because of the possible positive effects on
ADHD students in these difficult lecture type classrooms.

Performances on tests and

quizzes, observations of attention and behavior during lectures, teacher ratings, and
accuracy of assignments completed during study hall were studied in the research of Evans
& Pelham (1991). A double-blind placebo-controlled design using 9 male subjects ranging
in age from 11-15 years old with a diagnoses of ADHD according to DSM-IIIR were given
either methylphenidate (8 on methylphenidate and 1 on pemoline due to previous non
response to methylphenidate) or a placebo.

The study took place at a Summer Day

Treatment Program. For 90 minutes a day, during their 9 hour day, students participated in
a 60 minute American history class followed by a 30 minute study hall. Students were also
to be taught note taking skills in this class.

Monday through Thursday, the students

listened to the lecture and took notes. Every Tuesday through Thursday, the students took
a quiz on the previous day's notes with a cumulative test on Fridays. During the study hall
period, the students were given an assignment to complete with the remaining time to be
used to study their notes for the next day's quiz. No written material or text were provided
during study hall. Their notebooks were collected at the end of study hall and given back to
them at the beginning of the following class to insure all studying was done from notes
taken in class and took place in study hall.
Dependent measures in this study were academic performances on daily quizzes,
lecture question and answer assignments, and cumulative tests. Behavioral performances
included observations of aggression, verbal abuse, destruction of property/inappropriate
use of materials, cheating, interrupting, and talking to self. Teacher ratings on a Conners
Scale for inattentive/overactivity and oppositional/ defiant were performed at the end of each
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class.
The results of this study were the first to demonstrate that stimulants improved the
performances in young adolescents on measures that they would encounter in a regular
junior high school class.

Improvements in these subjects were both academic and

behavioral in nature. Improvements were the same with both the higher and lower doses of
medication which was the same found with younger subjects in previous studies. Grade
improvements averaged from a D- on placebo to a B- on medication which indicates that
school failure could be reduced in ADHD adolescents who benefit from stimulant
medication. It is important to note that the setting of this study was closely related to a
junior high school class so external validity could be insured. Also, the use of a study hall
more closely resembles a junior high school situation where assignments are completed
independently outside the regular classroom in a study hall or at home.

It might be

beneficial to provide a third dose of medication in the late afternoon to enhance the study
skills needed for homework at the junior high school level. It is important to mention that 3
of the 9 adolescents were not recommended for medication at the end of the study. One due
to adverse rebound at night which manifested itself as verbal confrontations with his
parents. The other two subjects did not have side effects but the parents chose not to
continue because these two students were on medication as children and they did not want
to continue stimulants. This study documented the benefits of stimulants to help ADHD
adolescents who potentially would have poor academic results function better in the
classroom. Careful monitoring is needed to adjust the child's dose and reduce side effects
(Evans & Pelham, 1991).
The results of studies involving stimulant treatment often show a positive effect on
the child's learning.

But when reviewing these studies one must take into account

methodological considerations. There are many different kinds of stimulant drugs which
may have different effects on a variety of academic tasks. Also, there is the controversy
over dosages. While a small dose may be beneficial to academic areas, a larger dose may
be needed for behavioral improvements. This higher dose, however, may actually impair
the academic gains of the drug (Sprague & Sleater, 1977; as sited in Gadow, 1983). The
schedule of when a child gets his medication and when it will wear off is also a
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consideration in the use of stimulants. Short-acting stimulants given in the morning would
not be helpful by the aftemoon.

Furthermore, the duration of treatment is important

especially when looking at standardized achievement test scores. Studies often look at the
short-term (e.g. weeks) effects of stimulants, but long-term effects (e.g. months or a
school year) are what is looked at when comparing standardized test scores from year to
year produced by the same ADHD child. Finally, the setting and the inclusion of other
therapies has a significant effect on how well a medication will work. Many studies
support the fact that medications work best with some type of behavior modification
implemented as well (Pelham, Carlson, Sams, Vallano, Dixon & Hoza, 1991). However,
there are also studies that conclude that while stimulants increase academic productivity, the
effect on standardized achievement tests are not especially strong, and some behavioral
interventions are clearly superior (Gadow, 1983).
The effect of stimulant medication on younger children as demonstrated by
performance in school has been studied extensively. What needs to be looked at now is the
effects of stimulant medication on the performances of older children, particularly
adolescents in school. Specifically, how does the use of stimulant medication effect the
academic performance on standardized achievement tests as compared to the fall and spring
test results of ADHD adolescents (both on and off stimulants) as well as the
behavioral/social standings of this population as compared to their status on a behavioral
improvement system? The purpose of the proposed study is to see if a combined stimulant
intervention/behavior improvement system facilitates greater gains on achievement tests and
a behavior improvement level system than the behavior improvement system alone on
ADHD junior high school adolescents.
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Chapter Three

Description of subjects
Ten subjects will be obtained for this study; 5 taking stimulants and 5 not taking
stimulants. The criteria for inclusion will be an IQ 80-120 according to a review of the
students' records. Also in these records must be a DSM-IV diagnosis of ADHD by a
psychologist or psychiatrist. The students must attended the same out of district school for
the emotionally disturbed, be between the ages of age 12-14, and be grade 7-8. The
criteria for exclusion will be that the student have no other psychiatric diagnosis (eg.
schizophrenia). Also the subjects must not be more than 4 years below grade level on the
KTEA (Kaufman Test of Educational Achievement) composite score. The sample will be
gathered by a review of records and an interview with nurse. Since the students' names
will not be used, medication will not be altered, IEP will be followed, and educational
delivery will not be changed than informed consent will only be obtained from the building
principal.

Design
The design of this research will be a causal comparison ex-post facto study. The
comparison will be between two populations of ADHD junior high school students, one
who is taking stimulants and one who is not, to see if stimulants cause a difference in
academic and behavioral achievement. This study will also be quasi-experimental in that
the groups are already placed (not random) and can not be changed by the researcher.
Subjects in both the experimental and control group will be matched as close as possible in
regards to IQ, academic levels, socioeconomic level (e.g. free lunch), classroom
assignment, classification, and home situation (e.g. foster care, single parent, etc.).
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Independent variables in the study will be a level of methylphenidate dose between .6mg/kg
and 1.0mg/kg for the medicated students and no stimulant intervention for the control
group. Dependent variables to be gathered for comparison will be the fall (Sept.) KTEA
and spring (March) KTEA test scores. Furthermore, the achievement level on the school
wide behavior improvement system will be compared from the same two time frames
(Sept./March).

Description of site
The study will be conducted at an out of district, county wide, special education
school. Important features of this setting are that it is an out of district placement for the
multiply handicapped population that is struggling with success in their hometown school.
The students in this particular study all will have an emotionally disturbed component in
their classification and will attend the junior/senior high school at the county school. The
school building houses approximately 150 junior/senior high school students. There are 6
junior high school self contained classrooms, and 12 high school homerooms. The junior
high school students spend their mornings in the same classroom with the same teacher.
Three periods a week, they leave to take physical education classes in the gymnasium.
These students are place in their classrooms according to their reading levels. Math class in
the junior high school is departmental so they may change classes and attend a class at their
math level. One period a week, the school psychologist comes in to run a group counseling
session.

Description of Instruments
The measurement tool used to determine the achievement of the subjects will be the
Kaufman Test of Educational Achievement brief from. The KTEA is a norm-referenced
individually administered achievement test for children grades 1 through 12. The brief
form produces standardized scores in reading, mathematics, spelling, and an overall test
composite with the mean set at 100 and standard deviations set at 15 (Kaufman &
Kaufman, 1985). The test takes about 30-40 minutes to administer to each child. This test
is given to the students in the fall or when they enter the district and again in the spring
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before IEP's are written.
Another measurement tool to be used in this study will be the school's own unique
behavior improvement system. The behavior modification system developed by the school
district involves a career advancement level system and a token economy that includes
wages per hour (class period) at the different levels (job titles).
examples:
unemployment

$3.00 per/hour

$150 per/week

clerk

$6.00 per/hour

$300 per/week

manager

$10.00 per/hour

$500 per/week

executive

$15.00 per/hour

$750 per/week

Each career step lasts for a 4 week period at which time the students are due for a
promotion. Promotions are given if you are able to pay your weekly bills on a consistent
basis. Each career step has its own special bills to pay. The first level is Unemployment
which includes such bills as public transportation, health insurance, security deposit, rent,
public utilities, and a savings account. The second level, Clerk, includes an added expense
of entertainment, larger rent, etc. Following Clerk is Manager which involves an actual
interview with the assistant principal with a properly completed job application, vehicle
registration, drivers permit (used as a hall pass), etc. Next, Executive candidates must type
a resume, dress for the interview as best they can, pay drivers license fees, and a mortgage.
Each career step has a built in savings amount to be put aside each week. After a
promotion the students get their savings along with their weekly paycheck. This money is
needed to make the larger bills associated with each new career step. If a child is unable to
pay a certain weeks' bills, they are left on that week until the following week when they are
required to pay the rest of their outstanding bills and the next weeks bills. If they are
unable to pay their bills at this time, then they drop back a full career step (eg. clerk week 3
goes back to unemployment week 3). Students are assigned fines for infractions like
fighting, cursing, unfinished work (off-task), personal target behaviors not being followed,
etc. Some of the more serious offenses, like fighting, may require removal from the
classroom which results in an automatic loss of the hourly wage earned in that time period,
and if they have to see the disciplinary officer than they are charged a court cost (1/2 a days
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pay). Suspensions result in the loss of a day's pay. Each student is given one paid sick
day per month (if they have a note), and all other absences are unpaid. The system allows
for properly behaving students to advance. A student's misbehavior will affect their career,
pay, and their ability to pay bills, just like in the real world. This token economy is tangible
and reality based which involves both immediate and delayed gratification.

Independent Variables
The use of stimulant medication with ADHD junior high school students will be the
independent variable in this study.

The ADHD students who are prescribed

methylphenidate by their private physician, and ADHD students who are not on
methylphenidate will be tracked.

Pretest scores will be gathered in September and

compared to the post test scores obtained in March between the medicated and unmedicated
students. Possible confounds of this study may be: forgotten doses at home, prescriptions
that are allowed to run out, different teachers for some of the subjects, possible substance
abuse, teacher bias towards medicated and unmedicated subjects, student behavior in the
presence of a substitute (deterioration), possible additions of new medications, withdrawal
from methylphenidate, or if one of the student leaves district. To address these possible
confounds more than the projected 10 subjects (5 in each group) will be used at the start to
allow for eliminated subjects due to any of the above mentioned confounds. To try and
eliminate teacher bias as it pertains to different subjects being taught by different teachers,
both a medicated and unmedicated ADHD subject should be chosen from the same room if
a subject is to be chosen at all from that room. The number of different rooms should be
kept to a minimum.

Examiners
Myself (head examiner) and other teachers in the district will administer the
K-TEA to all students for the spring assessment. Fall testing has already been completed by
the appropriate teachers. All teachers, and support staff will implement the behavior
improvement plan as outlined by the district guide. All staff have attended several inservices on the behavior improvement system implementation as well as a spring in-service
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as a refresher to the administration and scoring of the K-TEA. The involved teachers will
be told that their particular student will be involved in a study but they won't be told the
research questions or topics. After testing is completed, the head examiner will collect data
from the involved teachers. (ex-post facto in design here).

Measures of Dependent Variables
The standardized scores from the K-TEA will be entered into the computer to be
averaged and a standard deviation will be obtained. Behavior improvement levels will be
entered into the computer under an assigned number:
unemployment week 1

1

unemployment week 2

2

unemployment week 3

3

unemployment week 4

4

clerk week 1

5

clerk week 2

6

clerk week 3

7

clerk week 4

8

manager week 1

9

manager week 2

10

manager week 3

11

manager week 4

12

executive week 1

13

executive week 2

14

executive week 3

15

executive week 4

16

retirement from system

17

These achievement scores from the reading, mathematics, spelling and overall
composite sections of the KTEA will be entered into the computer, graphed and averaged
with standard deviations calculated.

The two sets of data from the medicated and

unmedicated groups will then be compared for possible differences in achievement.
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Procedure
Instructions to subjects will be no different from any other time when they are
administered these tests. Teachers will administer the tests as usual. Data for the behavior
improvement level gained by the subjects will be gathered on February 25, 1998, which
falls on a Wednesday. This is the chosen time due to the higher frequency of absenteeism
on Mondays and Fridays, it does not fall immediately before or after a holiday, it is before
the students are under any stress associated with spring testing, and hopefully, it will not be
affected by winter weather. The mentioned conditions tend to affect the behavior of many
students in our population.
The staff who normally have contact with the subjects will continue to have contact
with the subjects and nothing will change. The students will follow the normal procedures
of the district. The staff involved will be asked to test the subjects in this study first to
gather the data needed for analysis as early as possible.
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Chapter 4
Results

The methodology of this research study was quasi-experimental in design since the
groups were predetermined according to the population available. Therefore, measures
were taken to equalize the two groups being compared. These measures included race,
gender, I.Q., age, economic status (e.g. free lunch status), and family type (e.g. nuclear)
Each group contained 5 members. The stimulant medicated group had a mean full scale
intelligence quotient (FSIQ) of 98.8 and the non-medicated group had a mean FSIQ of 94.
Both of these scores fell within the normal range and differed by less than 5 points (see
Figure 1).

Figure 1
Mean IQ Scores of Both Groups
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Each group consisted of all males; four of each group were Caucasian and one in
each group was African American (see Tables 1 & 2). The mean ages of both groups were
between 13 and 14 and had a mean difference of less than 2 months (the non-medicated
group being slightly older).

Table 1
Demographic Information of ADHD Junior High Classified Students Using Ritalin
Age as of 3/98 (in months)
Name
173
subject 1R
162
subject 2R
subject 3R
179
151
subject 4R
5R
153
subject
163.6 (months)
mean age
means/percents
13.6 (years)
12.24 (months)
st. deviation

Gender
male
male
male
male
male
100% male

Race
white
white
white
white
black
80% white
20% black

FSIQ
94
103
95
101
101
98.8
4.02

Table 2
Demographic Information of ADHD Junior High Classified Students Not Using Ritalin
Name
Aae as of 3/98 (in months)
173
subject 1N
160
subject ZN
176
subject 3N
151
subject 4N
165
subject 5N
mean age
165 (months)
means/percents
13.75 (years)
10.07 (months)
st. deviation

Gender
male
male
male
male
male
100% male

Race
white
white
white
white
black
80% white
20% black

FSIQ
100
87
95
98
90
94
5.43

Other considerations in equalizing the groups were classification, family status and
economic resources (see Table 3). Of all subjects involved, 100% had an emotional
disturbance (ED) in their classification and it was their primary classification. Also, in both
of the groups, each contained two subjects who were classified ED alone. The other three
members of each group also had a learning disability as a secondary classification (e. g.
perceptually impaired, PI, or neurologically impaired, NI).
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Family status was determined by a review of the records. Three members in the
medicated group and two from the non-medicated group were from single parent homes
(see Table 3). The other two members in the medicated group were from either a foster
family or an extended family with grandparents, aunts and uncles, and cousins. The two
other members of the non-medicated group were from extended families and one was from
an intact nuclear family.
Table 3
Economic Status, Family Type, and Classification of Subjects
Lunch Status
Medicated Subjects
1
subject 1R
2
subject 2R
3
subject 3R
1
subject 4R
1
subject 5R

Non-Medicated
subject 1N
subject 2N
subject 3N
subject 4N
subject 5N

1
3
2
1
1
60% low income
20% low/middle
20% middle income
KEY:
1= free
2= reduced
3= full price

Family Type

Classification

4
2
2
2
3

ED/PI
ED/PI
ED
ED
ED/NI

4
4
1
2
2

ED/PI
ED/PI
ED
ED
ED/NI

50% single parent
30% extended family
10% nuclear family
10% foster care

60% multiple handicapped
40% E. D. only

1= intact nuclear
2= single parent
3= foster
4=extended

Economic status was determined by the school's lunch program. According to
forms filled out at the beginning of the year in regards to family income, each student is
categorized into one of three groups: free lunch, reduced lunch, or full price status. Three
subjects in each group were deemed eligible for free lunch (low economic status). One
student from each group was eligible for a reduced cost lunch (low/middle income status).
Finally, one student in each group has to pay full price for lunch (middle income status)
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In the experimental group data was collected in the form of the weight of each
subject and milligrams of methylphenidate per day. According to past research, this data
may prove important as it was found that levels around .7 mg/kg per day were found to be
optimal for both behavior and cognitive performances (Schachar, Tannock, Cunningham,
& Corkum, 1997).

Table 4
Medicated Groups Dose per Day per Weight
Subject
Subject
Subject
Subject
Subject

1R
2R
3R
4R
5R

Mean
Standard Deviation

Weight in Ibs.
118
120
116
81
92
105.4
17.74

Weight in kg.
54
55
53
37
41
48
8.37

Daily Dose
40
40
40
30
40
38
4.47

mg/ka
0.74
0.73
0.75
0.81
0.98
0.802
0.10

Other data collected was in the form of pre and post test scores from the Kaufman
Test of Educational Achievement, brief form (KTEA). These test are administered in the
beginning of the school year for new students to the district. For students returning to the
district, the pretest scores were derived from the previous year's end of year testing (last
year's post test scores).

Then, in April, before IEP's are developed, a post test is

administered to all students in the district. The results of these two tests are then compared
to identify areas of growth, how much growth, and areas that need additional remediation.
This information is useful in IEP meetings to establish new goals and objectives.
The ten students in this research study were administered the KTEA in March to
obtain post test scores. These scores were then compared to the pretest scores from either
September or April of 1997. The pretest results showed that the medicated group had a
mean standard score of 93.6 on the composite (overall) test section. The unmedicated
group's mean standard score on the pretest composite section was 85. This was a
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difference of more than 8 points. The post test standard scores on the composite were 98
for the medicated group and 86.8 for the non-medicated group, a difference of 11.2. Each
group demonstrated some overall growth (see Figure 2). The medicated group gained a
mean total of 4.4 points while the non-medicated group gained a mean total of 1.8 points.
Figure 2
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In closer analysis, in the medicated group subject number two's post test score
went down by 3 points (see Table 5, next page). This student refused to do a large portion
of the test. For example, when this student was presented with the word "Salute" on a
card, he was expected to demonstrate his comprehension of the word by saluting. The test
administrator's cue was to say, "Do what this says". He would not salute the test giver.
This behavior was demonstrated throughout the test. As a result, the mean standard
composite score for the medicated group was lowered.

Without his score, the mean

difference between the pre and post test scores would have been 6.25.
Conversely, subject number five in the non-medicated group post test score went
down by five points. It was noted by the teacher who gave the test that this student was
meticulous in his attempts at accuracy and demonstrated a desire to do well. He repeatedly
asked during the test how he was doing.
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Table 5
KTEA Composite Test Standard Scores
Medication
subject 1R
subject 2R
subject 3R
subject 4R
subject 5R
mean
st. deviation

Dretest post test +/83
86
+3
72
69
-3
118
122
+4
+6
122
128
+12
73
85
93.6
98
+4.4
24.52 25.64

No Medication
subject 1N
subject 2N
subject 3N
subject 4N
subject 5N
mean
st. deviation

pretest
74
88
88
96
79
85
8.60

post test +/79
+5
92
+4
83
-5
99
+3
+2
81
86.8
+1.8
9.43

Other results were obtained from the individual standard scores of reading,
mathematics, and spelling achievement between the pre and post test results, as well as age
and grade equivalents. In reading, the medicated group demonstrated the largest gains with
a mean standard score gain of +7.6 points. This converts to a growth of an average of
+1.8 grade levels in reading achievement or +2.1 years. However, the non-medicated
group had their smallest gains in the area of reading growth. Their mean standard score
gain was only +0.6 points. This score converts to an average grade level growth of +0.52
and only +0.42 years of reading achievement (see Table 6).
Table 6
KTEA Reading Post-Test Results

KTEA Reading Pretest Results
Medicated Subjects
standard grade aae
8.5
14.0
subject 1R
102
subject 2R
73
3.5
9.0
114
10.0
15.6
subject 3R
111
10.2
14.0
subject 4R
2.4
7.9
subject 5R
69
mean
93.8
6.9 12.1
st. deviation
21.3
3.7
3.4
achievement
+2.1
gained (mean)+7.6 +1.8
Non-medicated Subjects
subject 1N
86
5.2
6.2
subject 2N
92
92
6.7
subject 3N
91
5.2
subject 4N
5.7
subject 5N
88
mean
89.8 5.8
st. deviation
2.68 0.65
achievement
gained (mean)+0.6 +0.52

10.9
11.6
12.3
10.9
11
11.34
0.61

subject 1R
subject 2R
subject 3R
subject 4R
subject 5R
mean
st. deviation

subject 1N
subject 2N
subject 3N
subject 4N
subject 5N
mean
st. deviation

+0.42
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standard
106
68
109
126
98
101.4
21.3

86
88
94
98
86
90.4
5.74

arade
10.0
2.8
11.6
12.5
6.7
8.7
3.9

aae
15.6
8.3
17.0
18.0
12.3
14.24
3.9

6.2
5.7
7.3
6.7
5.7
6.32
0.48

11.6
11
12.9
12.3
11
11.76
0.62

In the area of mathematics, results demonstrated some growth in both groups. In
the medicated group mean standard scores increase an average of +5 points, +1.8 grade
levels and +2.1 years in mathematics achievement. The non-medicated group's growth
was less impressive with the mean standard score increasing by only +0.6 points, grade
level increased by +0.74, and age levels also grew by only +0.78 years in mathematics
achievement (see Table 7).

Table 7
KTEA Math Post-Test Results

KTEA Math Pretest Results
Medicated Subjects
standard
76
subject IR
80
subject 2R
117
subject 3R
subject 4R
111
75
subject 5R
mean
91.8
20.46
st. deviation
achievement
+5.0
gained (mean)
Non-medicated Subjects
subject 1N
74
subject 2N
89
subject 3N
98
105
subject 4N
74
subject 5N
88
mean
13.98
st. deviation
achievement
+0.6
gained (mean)

grade
4.8
5.0
12.6
10.9
3.8
7.42
4.02

am
10.3
10.6
18.3
14.9
9.3
12.68
3.80

+1.8

+2.1

4.4
5.8
7.4
7.1
4.4
5.82
1.43
+0.74

9.9
11.3
12.9
12.6
9.9
11.32
1.43

subject
subject
subject
subject
subject

1R
2R
3R
4R
5R

subject 1N
subject 2N
subject 3N
subject 4N
subject 5N
mean
st. deviation

standard
aaeg
82
79
118
130
75
96.8
25.31

84
96
85
98
80
88.6
8.85

arade
6.1
5.0
12.9
12.9
4.0
8.18
4.37

11.6
10.6
18.9
18.9
9.6
13.92
4.60

6.4
7.4
6.4
7.1
5.5
6.56
0.84

11.9
12.9
11.9
12.6
11
12.1
0.84

+0.78

Spelling results were somewhat different than the other findings. Like the other
test scores, the medicated group gained more mean standard score points (+4.2) than the
non-medicated group (+0.8). However, the medicated group gained less than a grade level
(+0.66) and less than a year of age (+0.86) in scores in spelling. The non-medicated group
also achieved less than a grade level (+0.78) and less than a year in age levels (+0.76) in
achievement in spelling (see Table 8 next page).
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Table 8
KTEA Spelling Post-Test Results

KTEA Spelling Pretest Results
Medicated Subjects
standard
85
subject 1R
73
subject 2R
118
subject 3R
113
subject 4R
92
subject 5R
96.2
mean
18.97
st. deviation
achievement
gained (mean) +4.2
Non-medicated Subjects
61
subject 1N
90
subject 2N
84
subject 3N
94
subject 4N
86
subject 5N
83
mean
1.28
st. deviation
achievement
+0.8

grade age
5.2
10.9
9.0
3.6
12.9
18.9
9.2
14.6
5.6
11.0
7.3
12.88
3.74 3.93
+0.66

3.3
5.6
4.9
5.6
5.2
4.92
0.95
+0.78

subject 1R
subject 2R
subject 3R
subject 4R
subject 5R

standard
87
71
126
122
96
100.4
23.37

age
grade
11.6
5.9
8.6
3.0
12.9
18.9
17.6
11.8
12.0
6.2
7.96 13.74
4.22 4.35

+0.86

8.9
11.0
10.3
11.0
10.9
10.42
0.90
+0.76

subject
subject
subject
subject
subject

1N
2N
3N
4N
5N

63
94
79
97
86
83.8
1.49

4.9
6.7
4.6
6.7
5.6
5.7
.98

10.3
12.3
10.0
12.3
11.0
11.18
1.08

Results for behavior were calculated using a level system token economy scale.
The behavior improvement system used in the school was piloted last year in both a junior
and senior high school room. This year the system was implemented school wide. This
meant that all students started on the same level or employment step of Unemployment
week 1 (1). Post test scores were gather near the end of February. All medicated subjects
were off the Unemployment level which takes four straight weeks of acceptable behavior to
achieve (see table 9). The lowest level of the medicated group in the post test was on step 5
or Clerk week 1. Next, was a student who made it to Clerk week 4 (step 8) followed by a
student who made it to Manager week 1 (step 9). The next two highest levels achieved by
the medicated group were Executive week 1 (13) and a student who had reached retirement
(17). Retirement is the highest level in the program and the student has to earn enough
money at each employment level to pay his weekly bills while avoiding fines and court
costs. He must also exhibit good behavior, work on personal target behaviors, fill out job
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applications correctly, read and sign a lease, apply for a driver's permit, driver's license,
and car registration, pass interviews with the assistant principal, and be interviewed by an
administrator from another campus (someone they never met). Out of a population of 183,
only 20 students have reached the retirement level.
Table 9
Behavior Levels Achieved by Both Groups
Medicated
subject 1R
subject 2R
subject 3R
subject 4R
subject 5R
mean
st. deviation

PreBMod Level PostBModLevel Non-medicated PreBMod Level PostBModLevel
11
1
8
subject 1N
1
1
1
subject 2N
1
5
9
1
17
subject 3N
1
1
1
subject 4N
13
1
1
1
9
subject 5N
1
4.6
1
10.4 mean
1
4.98
4.67 st. deviation

The non-medicated group at the time of post testing still had 3 subjects on
Unemployment week 1 (1). One student made it to Manager week 1(9) and the highest
level achieved was Manager week 3 (11). The mean average for achievement on the level
system was 10.4 for the medicated subjects ( Manager week 2). For the non-medicated
group, the mean average for achievement was 4.6 (Unemployment week 4).
Overall the mean averages collected from these tests support the use of stimulants to
improve academic and behavior performances. Medicated students' mean scores on the
KTEA were higher than the non-medicated group's scores. Behaviorally, the medicated
students achieved higher levels on the level system implemented in the school.

36

Chapter 5
Discussion

Brief review
The purpose of this research was to determine if the use of stimulants in ADHD
adolescents would have a positive impact on their academic and/or behavior performances.
Subjects were selected for each group (medicated and non-medicated) on the basis of their
diagnosis of ADHD without other psychological problems. Each group was then equalized
in regards to similar full scale intelligence quotients, ethnic background, economic status,
educational classification, age, and gender. The medicated group was analyzed for daily
dosage amounts of stimulants to insure closely matched milligrams of stimulant per
kilograms of body weight. Standardized pretest scores on the KTEA were collected in the
Fall and post test scores were obtained in the Spring for comparison. Behavior levels
according to the school-wide behavior improvement system were gathered in the Fall and
Spring as well.

Summary of Results
The results, despite showing a greater academic achievement in the given school
year by the medicated students, are not statistically significant at the .05 level, a level
generally acceptable in the field of education. On the composite test scores from the KTEA
the medicated group gained a mean of 4.4 points, where as the non-medicated group gained
a mean of 1.8 points. The reading section of this test demonstrated that the medicated
group gained a mean of 7.6 points and the non-medicated group gained only a mean of 0.6
points. In math, the medicated group's mean average growth was 5.0 points and the nonmedicated group's mean point gain was 0.6 points. Spelling scores for the medicated
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group had a mean gain of 4.2 points and the non-medicated group gained a mean of 0.8
points. The behavioral improvements were the strongest results produced, yet they also
fell short of being statistically significant at the .05 level. The behavioral results show the
medicated group obtaining a level of 10.4 from a starting point of 1 while the nonmedicated group reached a level of 4.6 from a starting point of 1.
The results obtained from this study do possess practical significance which
suggests that ADHD adolescents can benefit from the use of stimulant medication. Despite
the fact that statistical significance was not obtained, looking at the results in a practical or
functional respect allows us to see the growth made by the medicated group vs. the nonmedicated group. The stimulant group grew 1.8 grade levels in both reading and math
while the non-medicated group advanced only .52 grade levels in reading and .74 grade
levels in math. This shows the stimulant group making twice as much progress as the nonmedicated group in these two school subjects on a standardized test. The spelling results
were less impressive with the medicated group gaining only .66 grade levels and the nonmedicated group achieving just .78 grade levels.
These low levels of grade status achievement in spelling could have been
confounded by what is known as the "ceiling effect". For example, subject 3R from the
stimulant group had a pretest spelling grade level score of 12.9 and a standard score of
118. On his post test, his grade level remained at 12.9 ( the highest or ceiling score of the
test ) but his standard score improved to 126, a difference of +8 points. While this child
may now be spelling at the college level the test still shows his level at 12.9, the ceiling
level of the test.

Similarities and Differences to Previous Research
As reported by Gadow (1983), stimulant used did not have a robust effect on
standardized scores. This research study's results are consistent with Gadow's in that here
too there were no statistically significant findings using standardized scores in regards to
ADHD subjects and stimulants.

However, in the Evans and Pelham (1991) study

conducted on adolescents, significant achievements were noted by the stimulant group
when compared to the non-stimulant group using curriculum-based assessment procedures
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as opposed to this study's use of standardized test scores.
In a study by Tannock, Schachar, Carr, and Logan (1989) it was also demonstrated
that stimulants enhanced academic functioning and improved overt behavior. This study,
however, was conducted on children between the ages of 6 and 11, not adolescents. Time
trailed arithmetic and letter search tasks were also used instead of standardized tests.
One noted problem in respect to dosage levels was discussed in an article by
Swanson, Cantwell, Lerner, McBurnett, and Hanna (1991). They found that often larger
or older children were given higher doses of methylphenidate which had gone past the
.6mg/kg level and this caused "cognitive toxicity". While the higher dose had a positive
effect on behaviors not achieved at a lower dose, this higher dose tended to hinder
academic achievement. The students in this research study had a mean daily stimulant dose
of .802 which had a stronger behavioral effect than academic effect.
In a more recent study (Schachar, Tannock, Cunningham, & Corkum, 1997), it
was noted that the optimal dosage of stimulants would be .7mg/kg. This increase from the
earlier study still is less than the mean average dose used in this research study.
Furthermore, the main focus of the study by Schachar et. al. was on ADHD behaviors
( hyperactivity and impulsiveness ) in the classroom and at home and did not focus on
academic improvements (reading and math level achievements).

Implications
Due to the small sample size implications from this study are weak. However, the
results implied that stimulants can help ADHD children improve areas of their behavior as
well as areas of academics such as reading and math. ADHD adolescents need to see some
improvement in their achievements by the time they reach junior high school or thoughts of
dropping out may become a concern. It is important to provide these children with the
tools they need to be successful in school, and to maintain their motivation to remain in
school when they reach high school.
The use of stimulants in ADHD adolescents may improve the child's self-esteem by
allowing the child to achieve success. The medicated students in this study achieved higher
levels of success in a work-based level improvement system. The behavior modification
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system developed by the school district and used in this study involved a career
advancement level system and a token economy that includes wages per hour (class period)
at the different levels (job titles). The levels in this system start at "unemployment" which
is the most restrictive level to be on. As behavior improves, the student then becomes
eligible for a promotion to the "clerk" level. After four weeks on that level, an interview is
conducted by the assistant principal and possibly a promotion to "manager". The next level
of achievement is the "executive" level. Finally, if a child has met all required behavior
improvements at the various levels, he is then allowed to make an appointment for a
retirement interview. Retirement is the least restrictive level and contains the most rewards
and benefits. It was noted at the site of this research that students demonstrated a stronger
desire to be a "manager" than to be "unemployed".

More students receiving

methylphenidate had achieved levels like "clerk", "manager", "executive", and "retirement"
than those students receiving no medication. When asked their levels for this research it
was noted by the surveyor that the responses of the higher achievers in the medicated group
answer the question with an upbeat and proud tone.

Conversely, those on

"unemployment" tended to answer with, "I don't know what level I'm on."

Limitations
This study was conducted with 5 members in both groups for a total of 10 students
(n = 10). With such a small sample, no reliable data were collected to support the use of
stimulants to improve the academic or behavioral levels of ADHD adolescents ( no scores
derived from testing were significant at the .05 level using an ANOVA ).
All students did not receive their morning doses at the same time. Some students
received their medications at home around 7:30AM and some others received their dose at
school around 8:30AM. Those that received their medication at school, are those who we
are sure received their doses. If the child took their medication at home, there was no way
of insuring that a strict regimen was followed.
Another confounding variable was that 2 students in each group were from another
classroom with another teacher. The teaching styles may have differed enough to have
interfered with the test scores as well as the consistent use of the behavior modification
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system. The student population in each room also develops its own dynamics and the
aggression level, distractible situations that emerge, as well as the personalities of each
child may play a part in learning.
Misclassification sometimes does occur by the child study teams. Children who are
actually learning disabled are classified as emotionally disturbed and vice versa. Some
students who had a single classification of E. D. may have in fact had a learning problem as
well. This would have resulted in unequal groups as far as learning potential.
The way each teacher administers the KTEA test may have effected the results. If a
non-medicated student has developed a caustic relationship with the teacher, the teacher
may not give the student equal opportunity to respond to the questions. Teacher attitudes
towards abrasive students were documented by Whalen, Henker, and Dotemoto in 1980.
They found that teachers tended to be more intense and controlling towards unmedicated
hyperactive subjects.
The standard deviations demonstrated a much larger variation from the mean with
the medicated group than it did from the non-medicated group. While the non-medicated
group had a standard deviation on the composite KTEA pre and post test of 8.60 and 9.43
respectively, the medicated group's standard deviation was 24.52 (pre) and 25.64 (post) on
the same test.

The difference between the medicated groups' standard deviation is more

than twice that of the non-medicated groups'. The larger deviation suggests that the
medicated group had a wide spectrum of individual differences with members having both
high and low scores obtained from pre and post test composites. This pattern was repeated
across all academic areas.

The behavior scores of both groups had more consistent

standard deviations with the post scores' standard deviation being 4.67 for the medicated
group and 4.98 for the non-medicated group.

Areas of Possible Future Research
Research pertaining to the use of stimulants and ADHD children has been extensive
through the years.

More and more doctors are looking to continue medication into

adulthood. Future research should focus on the effects of stimulants on academic growth
and behavioral improvements in the teen years as well as with adults on medication.
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Research on stimulant use with ADHD teens could expanded to include college
performance, SAT scores, HSPT scores, job performances, and drop out rates between
medicated and non-medicated students.
One of the first research studies conducted involving junior high school students
and the use of stimulants was done in 1991 by Evans and Pelham. Instead of the structure
and dynamics of an elementary classroom where all work is basically completed in the
room, Evans and Pelham used a lecture hall. Furthermore, students were to take notes and
use their notes in the study hall that followed the class to answer questions. Curriculumbased assessment was used in the form of quizzes and tests. This format was designed to
simulate a junior high school setting. Future studies involving adolescents with ADHD
should focus on settings that more closely represent the mainstream junior senior type high
school.

Even college settings could yield useful data in our attempts to remediate the

behaviors and academic achievements of this population.
Another consideration for future studies is to compare the achievements based on a
variety of assessment tools. Much of the research from the past was based on tools
designed for each individual study. What measures could we take to improve the ADHD
adolescent's standardized test scores?

Conclusion
In summary, this study looked to support the use of stimulants with ADHD
adolescents in order to improve their academic and behavioral achievements. The results of
this study demonstrated positive academic growths when the grade level achievements of
the pretest and post-test grade level equivalent scores from the Kaufman Test of
Educational Achievement were compared. Furthermore, positive behavioral growth was
demonstrated by the behavior levels achieved by the stimulant group which surpassed the
non-medicated group's behavior achievement levels. Although statistical tests were not
significant, these results hold practical significance for teachers and other staff working
with this population of ADHD adolescents as well as the students themselves.

It is

important at this age for the ADHD student to see the benefits of his efforts and to feel
some success.
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Does this imply that stimulants may or may not be beneficial with ADHD in the teen
years?

No, but more research needs to be conducted.

Furthermore, this study used

standardized test scores as a measure and past research had similar results with these types
of tests.

Conversely, significant improvements were found in other research that used

curriculum-based assessment practices.

Stimulant drugs have been shown to increase

academic productivity in some hyperactive children ( Gadow, 1983). Douglas, Barr,
O'Neil, and Britton (1985) also found that stimulant use improved academic, learning,
cognitive, and behavior measures in the classroom in children with ADHD as well as with
adults in similar situations.

Future studies that focus on using curriculum-based

assessment to see the benefits of what the ADHD adolescent can learn in the classroom
instead of standardized achievement measures based on a nationally normed population
could be the focus of research. It could be that ADHD adolescents could benefit from the
the use of stimulants in the classroom but further research needs to be conducted in order to
find a long term solution to help these children on standardized tests.
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